Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: Cardamom and Topical Roseomonas in Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the use of Cardamom and topical Roseomonas for atopic dermatitis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cardamom
  • Topical Roseomonas (Roseomonas mucosa)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis, Eczema | Phase 2 | Status: RECRUITING